Cargando…

Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors

Pulmonary arterial hypertension (PAH) is a fatal disease characterized by a progressive increase in pulmonary arterial pressure leading to right ventricular failure and death. Activation of the endothelin (ET)-1 system has been demonstrated in plasma and lung tissue of PAH patients as well as in ani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yahan, Tian, Xiao Yu, Huang, Yu, Wang, Nanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950948/ https://www.ncbi.nlm.nih.gov/pubmed/24701204 http://dx.doi.org/10.1155/2014/374075

Ejemplares similares

The role of endothelin-1 in pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2014)

Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism
por: Tsang, John Y. C., et al.
Publicado: (2012)

Membrane depolarization is required for pressure-dependent pulmonary arterial tone but not enhanced vasoconstriction to endothelin-1 following chronic hypoxia
por: Norton, Charles E, et al.
Publicado: (2020)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?
por: Goncharova, Elena A., et al.
Publicado: (2020)

Endothelin-Dependent Vasoconstriction in Human Uterine Artery: Application to Preeclampsia
por: Dechanet, Clotilde, et al.
Publicado: (2011)

β(2)-Adrenergic Receptor-Dependent Attenuation of Hypoxic Pulmonary Vasoconstriction Prevents Progression of Pulmonary Arterial Hypertension in Intermittent Hypoxic Rats
por: Nagai, Hisashi, et al.
Publicado: (2014)

Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection
por: Parikh, Rushi V., et al.
Publicado: (2016)

Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension
por: Lu, Yen-Yu, et al.
Publicado: (2022)

Pulmonary Artery Vasoconstriction Due to Bronchial Obstruction
por: Saliba, Thomas, et al.
Publicado: (2022)

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009)

Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension
por: Carratu, Pierluigi, et al.
Publicado: (2008)

Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2018)

Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
por: Tynan, Timothy, et al.
Publicado: (2019)

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)

Distortion of K(B) estimates of endothelin‐1 ET(A) and ET(B) receptor antagonists in pulmonary arteries: Possible role of an endothelin‐1 clearance mechanism
por: Angus, James A., et al.
Publicado: (2017)

Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension
por: Tanaka, Mariko, et al.
Publicado: (2017)

Lung Function, Inflammation, and Endothelin‐1 in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension
por: Low, Andrew, et al.
Publicado: (2018)

Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery
por: Knock, Greg A., et al.
Publicado: (2008)

S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension
por: Ban, Yiqian, et al.
Publicado: (2019)

Inhibiting miR-1 attenuates pulmonary arterial hypertension in rats
por: Liu, Yun, et al.
Publicado: (2021)

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
por: Opitz, Christian F., et al.
Publicado: (2008)

Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
por: Badagliacca, Roberto, et al.
Publicado: (2020)

Emerging roles of let-7d in attenuating pulmonary arterial hypertension via suppression of pulmonary artery endothelial cell autophagy and endothelin synthesis through ATG16L1 downregulation
por: Ou, Minghui, et al.
Publicado: (2020)

Mitochondrial transplantation attenuates hypoxic pulmonary vasoconstriction
por: Zhou, Juan, et al.
Publicado: (2016)

Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats.
por: Batalha, Joao R F, et al.
Publicado: (2002)

The Xanthine Derivative KMUP-1 Attenuates Serotonin-Induced Vasoconstriction and K(+)-Channel Inhibitory Activity via the PKC Pathway in Pulmonary Arteries
por: Dai, Zen-Kong, et al.
Publicado: (2015)

TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries
por: Murtaza, Ghulam, et al.
Publicado: (2017)

Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H(2)S-synthesizing pathways
por: Prieto-Lloret, Jesus, et al.
Publicado: (2015)

VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
por: Hamidi, Sayyed A, et al.
Publicado: (2011)

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
por: Correale, Michele, et al.
Publicado: (2018)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

Long-Term Effect of a Vaccine Targeting Endothelin-1 Receptor Type A in Pulmonary Arterial Hypertension
por: Dai, Yong, et al.
Publicado: (2021)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Piezo1 Channel Activation Reverses Pulmonary Artery Vasoconstriction in an Early Rat Model of Pulmonary Hypertension: The Role of Ca(2+) Influx and Akt-eNOS Pathway
por: Porto Ribeiro, Thais, et al.
Publicado: (2022)

Effects of Rosiglitazone on Heat Shock Protein and the Endothelin System in Deoxycorticosterone Acetate-Salt Hypertensive Rats
por: Bae, Eun Hui, et al.
Publicado: (2008)

Enhanced Endothelin-1 Mediated Vasoconstriction of the Ophthalmic Artery May Exacerbate Retinal Damage after Transient Global Cerebral Ischemia in Rat
por: Blixt, Frank W., et al.
Publicado: (2016)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87blivofpb3i66sv16trsr1dba